Reposting from YMB. This sounds authentic and sincere to
Reposting from YMB. This sounds authentic and sincere to me.
Joe 6 minutes ago
As some of you know I am a physician and head of a large anesthesia group of one of the largest medical systems in Mississippi.
Unlike almost everyone on this board,I actually have used this drug on two patients. My experience is both sobering and extremely hopeful.
Early in December my 88 year old mother in law contracted Covid and by December 4th was hospitalized with it. She deteriorated very quickly and by December 8th was struggling to breath despite the latest in SOC which included Remdisivir and Decadron. I had already had Covid and was staying with her that night and contacted the company for a compassionate dose of LL to give to her. Unbelievably Nader and Scott Kelly helped me go through the legal hoops snd I had the drug here by December 10. Unfortunately my mother in law had further deteriorated and her inflammatory markers were out of the viable range. She received her first dose but died the next day.
I kept the second dose in the fridge and sure enough last week my favorite OR pharmacist became very ill with Covid and went to the ER, received IV decadron, Remdisivir and antibiotics for superinfection snd sent home on oxygen because our hospital is full. Her lungs showed pneumonia and her sats on oxygen were 90-91 percent. As a physician in Mississippi I explained the risk benefits of an experimental drug and she agreed to receive the LL. She actually did worse the following day but I had read that it takes 72 hours to take effect. I was alarmed though early on as I’ve seen multiple patients die within days of the condition she was in and if those patients did make it it was weeks snd months of pulmonary and other organ disfunction associated with their survival. However, at the 72 hour mark she quit needing breathing treatments and the fever broke. By hour 48 she just felt tired snd her cough was largely gone. It was really like a death blanket was taken off of her. I’m sitting here writing this still in awe of what just happened. She’s alive and going to be fine with no long term effects.. I know this is just observational and in no way can be used to change a practice, but by God I’m convinced the CD12 data will be off the charts positive and soon I’ll be able to give it to all my serious and critical patients if there is enough left.
Cheers to the end of 2020.
23
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...
Continue Reading
FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...
Continue Reading
A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...
Continue Reading
CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...
Continue Reading
York Space Systems: Under Legal Fire You ever hear the one about York Space Systems? Yeah, their ticker YSS is buzzing for all the wrong reasons. Not even a year out from their IPO, and already they're tangled in a class action lawsuit that's got investors with their heads in their hands. ClaimsFiler, a shareholder information outfit, just blasted out a reminder for...
Continue Reading
IFA 2026 Reveals a Game Changer: ToolDance X1 Listen up, because ToolDance just threw a curveball into the CNC world with the launch of their X1 Smart Desktop CNC Mill at the IFA 2026 in Berlin. This isn't just another gadget—it's a real player aiming to bring manufacturing muscle right to your desktop. Will Wang, the genius behind ToolDance, wants to democratize CNC...
Continue Reading
Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....
Continue Reading
Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...
Continue Reading
IFA Unveils a Game-Changer for Senior Living Imagine having a helper at home that not only looks out for your safety but also keeps you company. That's exactly what Tuya Smart's new AI creation, Doova, is set to do. Unveiled at the IFA 2026, Doova isn't just another gadget—it’s a big leap for folks choosing to live out their golden years independently. Navigating...
Continue Reading
LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Recent Class Action Lawsuit Against Celsius Holdings Recently, Celsius Holdings, Inc. (NASDAQ: CELH) has found itself at the center of a significant legal challenge. This class action lawsuit, filed by a prominent law firm, seeks to address serious allegations involving the company's financial disclosures and dealings with PepsiCo, Inc. The Accusations...
Continue Reading
Five Star Bancorp's Dividend Announcement Five Star Bancorp (Nasdaq: FSBC) is pleased to share exciting news regarding its latest shareholder return strategy. The company has declared a cash dividend amounting to $0.20 per share on its voting common stock. This marks a continuing commitment to delivering value to its shareholders and is a pivotal part of the firm’s...
Continue Reading
Enovix Experiences Stock Decline Post Q3 Report Enovix Corporation (NASDAQ: ENVX) is facing a significant drop in its stock price as investors react to its recent third-quarter financial results. The company reported quarterly losses and provided guidance for the upcoming quarter that did not meet market expectations, leading to a decline in share value. Details of the...
Continue Reading
Borregaard ASA Announces Share Repurchase Initiative Borregaard ASA, known by the ticker OSE: BRG, is set to execute a strategic share repurchase program aiming to enhance shareholder value. This initiative involves the buyback of up to 200,000 shares of the company’s outstanding common stock. Purpose of the Share Repurchase Program The primary goal of this repurchase...
Continue Reading
Forian's Strategic Move to Acquire Kyber Data Science Forian Inc. (Nasdaq: FORA), a prominent data science company, is making headlines with its recent acquisition of Kyber Data Science LLC. This move is set to enhance Forian's capabilities in the healthcare analytics arena while also enabling the company to expand into the financial services sector. Kyber Data Science: A...
Continue Reading